144 related articles for article (PubMed ID: 3325158)
1. Orbital lymphoproliferative and inflammatory lesions.
White V; Rootman J; Quenville N; Worth A; Robertson W
Can J Ophthalmol; 1987 Dec; 22(7):362-73. PubMed ID: 3325158
[TBL] [Abstract][Full Text] [Related]
2. Cytologic evaluation of lymphoproliferative lesions of the orbit/ocular adnexa: an analysis of 46 cases.
Laucirica R; Font RL
Diagn Cytopathol; 1996 Sep; 15(3):241-5. PubMed ID: 8955609
[TBL] [Abstract][Full Text] [Related]
3. Polyclonal orbital and systemic infiltrates.
Rootman J; Patel S; Jewell L
Ophthalmology; 1984 Sep; 91(9):1112-7. PubMed ID: 6493720
[TBL] [Abstract][Full Text] [Related]
4. Lymphoid proliferations in the orbit: malignant or benign?
van der Gaag R; Koornneef L; van Heerde P; Vroom TM; Pegels JH; Feltkamp CA; Peeters HJ; Gillissen JP; Bleeker GM; Feltkamp TE
Br J Ophthalmol; 1984 Dec; 68(12):892-900. PubMed ID: 6391535
[TBL] [Abstract][Full Text] [Related]
5. Lymphoid infiltrates of the orbit and conjunctiva. A morphologic and immunophenotypic study of 99 cases.
Medeiros LJ; Harris NL
Am J Surg Pathol; 1989 Jun; 13(6):459-71. PubMed ID: 2658631
[TBL] [Abstract][Full Text] [Related]
6. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic option for orbital atypical lymphoid hyperplasia.
Talaulikar D; Tridgell D; Leong D; Dahlstrom JE; Cherian M; Prosser I; Sunderland K
Clin Exp Ophthalmol; 2010 Dec; 38(9):892-4. PubMed ID: 20662847
[TBL] [Abstract][Full Text] [Related]
8. Orbital imaging: a pattern-based approach.
Meltzer DE
Radiol Clin North Am; 2015 Jan; 53(1):37-80. PubMed ID: 25476173
[TBL] [Abstract][Full Text] [Related]
9. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
10. Cell typing in lymphoproliferative disorders. Use of a sensitive hemadsorption technique for sections of normal and abnormal lymphoid tissue.
Wood WG; Hood P; Rippey JH
Am J Surg Pathol; 1981 Jun; 5(4):369-79. PubMed ID: 7023259
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-related atypical lymphoproliferative disorders in Waldeyer's ring: a clinicopathological study of 9 cases.
Kojima M; Nakamura N; Itoh H; Shimizu K; Shimizu K; Matsuda H; Tamaki Y; Masawa N; Nakamura S
Pathobiology; 2010; 77(4):218-24. PubMed ID: 20616617
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of lymphoproliferative disorders: experience of a single institution in the long-term follow-up of discordant cases.
Sadek I; Greer W; Foyle A
Clin Invest Med; 2000 Dec; 23(6):366-75. PubMed ID: 11152404
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's disease-like lymphoproliferative disorders in patients with different underlying immunodeficiency states.
Tinguely M; Vonlanthen R; Müller E; Dommann-Scherrer CC; Schneider J; Laissue JA; Borisch B
Mod Pathol; 1998 Apr; 11(4):307-12. PubMed ID: 9578079
[TBL] [Abstract][Full Text] [Related]
14. [Lymphoproliferative diseases of the orbit and appendages of the eye].
Nechesniuk SIu; Probatova NA; Grishina EE; Kovrigina AM; Tupitsyn NN; Sholokhova EN
Arkh Patol; 2001; 63(1):27-32. PubMed ID: 11242851
[TBL] [Abstract][Full Text] [Related]
15. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
16. Histologic criteria for distinguishing between benign and malignant extranodal lymphoid infiltrates.
Burke JS
Semin Diagn Pathol; 1985 Aug; 2(3):152-62. PubMed ID: 3916552
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography of lymphoproliferative disease of the orbit. Report of 50 patients.
Weber AL; Dallow RL; Oot RF
Acta Radiol Suppl; 1986; 369():333-6. PubMed ID: 2980490
[TBL] [Abstract][Full Text] [Related]
18. Ocular adnexal lymphoproliferative lesions.
Liesegang TJ
Mayo Clin Proc; 1993 Oct; 68(10):1003-10. PubMed ID: 8412350
[TBL] [Abstract][Full Text] [Related]
19. MRI patterns in orbital malignant lymphoma and atypical lymphocytic infiltrates.
Akansel G; Hendrix L; Erickson BA; Demirci A; Papke A; Arslan A; Ciftci E
Eur J Radiol; 2005 Feb; 53(2):175-81. PubMed ID: 15664279
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and patterns of renal involvement in imaging of malignant lymphoproliferative diseases.
Bach AG; Behrmann C; Holzhausen HJ; Katzer M; Arnold D; Spielmann RP; Surov A
Acta Radiol; 2012 Apr; 53(3):343-8. PubMed ID: 22287149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
